Herbert B. Slade

3.5k total citations
62 papers, 2.6k citations indexed

About

Herbert B. Slade is a scholar working on Epidemiology, Immunology and Rehabilitation. According to data from OpenAlex, Herbert B. Slade has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 19 papers in Immunology and 17 papers in Rehabilitation. Recurrent topics in Herbert B. Slade's work include Wound Healing and Treatments (17 papers), Immunotherapy and Immune Responses (11 papers) and Pressure Ulcer Prevention and Management (10 papers). Herbert B. Slade is often cited by papers focused on Wound Healing and Treatments (17 papers), Immunotherapy and Immune Responses (11 papers) and Pressure Ulcer Prevention and Management (10 papers). Herbert B. Slade collaborates with scholars based in United States, Australia and United Kingdom. Herbert B. Slade's co-authors include Richard L. Miller, Mark A. Tomai, Mary Owens, John F. Gerster, Bernd Benninghoff, Stephen K. Tyring, István Arany, Michael Smith, Margaret Stanley and Daniel McDermott and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

Herbert B. Slade

58 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Herbert B. Slade United States	26	1.0k	779	506	477	412	62	2.6k
M. Goos Germany	24	918 0.9×	652 0.8×	1.4k 2.7×	624 1.3×	157 0.4×	87	2.9k
Sławomir Majewski Poland	27	1.2k 1.2×	485 0.6×	679 1.3×	505 1.1×	72 0.2×	134	2.5k
Jane Sterling United Kingdom	27	1.5k 1.5×	635 0.8×	242 0.5×	398 0.8×	61 0.1×	52	2.4k
Elizabeth A. Mauldin United States	26	481 0.5×	434 0.6×	435 0.9×	191 0.4×	162 0.4×	87	2.8k
J. Clark Huff United States	31	868 0.9×	721 0.9×	593 1.2×	186 0.4×	88 0.2×	70	3.2k
Larry Ellingsworth United States	27	566 0.6×	918 1.2×	340 0.7×	462 1.0×	83 0.2×	55	3.6k
Kathleen J. Smith United States	30	1.1k 1.0×	275 0.4×	1.0k 2.1×	928 1.9×	34 0.1×	142	3.0k
Teresa Greenwell‐Wild United States	28	516 0.5×	1.5k 1.9×	224 0.4×	350 0.7×	460 1.1×	35	4.1k
Henry G. Skelton United States	35	1.3k 1.3×	354 0.5×	1.4k 2.7×	1.1k 2.4×	38 0.1×	163	3.8k
Jean‐Pierre Molès France	27	722 0.7×	644 0.8×	416 0.8×	765 1.6×	90 0.2×	120	3.1k

Countries citing papers authored by Herbert B. Slade

Since Specialization

Citations

This map shows the geographic impact of Herbert B. Slade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert B. Slade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert B. Slade more than expected).

Fields of papers citing papers by Herbert B. Slade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert B. Slade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert B. Slade. The network helps show where Herbert B. Slade may publish in the future.

Co-authorship network of co-authors of Herbert B. Slade

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert B. Slade. A scholar is included among the top collaborators of Herbert B. Slade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert B. Slade. Herbert B. Slade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hee, Christopher K., Herbert B. Slade, & Samuel E. Lynch. (2025). Safety of Exogenous Recombinant Human Platelet‐Derived Growth Factor‐ BB ( rhPDGF ‐ BB ) for Medical and Cosmetic Applications: A Review. Journal of Cosmetic Dermatology. 25(1). e70636–e70636.

Sarkaria, Inderpal S., Linda W. Martin, David C. Rice, et al.. (2023). Pafolacianine for intraoperative molecular imaging of cancer in the lung: The ELUCIDATE trial. Journal of Thoracic and Cardiovascular Surgery. 166(6). e468–e478. 24 indexed citations

Herskovitz, Ingrid, Flor MacQuhae, Jaime E. Dickerson, et al.. (2017). Opioids’ Effect on Healing of Venous Leg Ulcers. Journal of Investigative Dermatology. 137(12). 2646–2649. 15 indexed citations

Cazzell, Shawn, Darrell L. Lange, Jaime E. Dickerson, & Herbert B. Slade. (2015). The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial. Advances in Wound Care. 4(12). 711–718. 48 indexed citations

Lange, Darrell L., Sarah Ramsay, Lei Shi, et al.. (2015). Anti-inflammatory Effects of Clostridial Collagenase. Journal of the American Podiatric Medical Association. 105(6). 509–519. 13 indexed citations

Kirsner, Robert S., et al.. (2012). Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. The Lancet. 380(9846). 977–985. 123 indexed citations

Marston, William A., et al.. (2011). Variables Affecting Healing of Venous Leg Ulcers In a Randomized, Vehicle-Controlled Trial of Topical Cellular Therapy. Journal of Vascular Surgery. 55(1). 303–303. 4 indexed citations

Quirk, Christopher J, Kurt Gebauer, Brian De’Ambrosis, Herbert B. Slade, & Tze‐Chiang Meng. (2010). Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.. PubMed. 85(6). 318–24. 55 indexed citations

Slade, Herbert B., et al.. (2009). Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials. Photodermatology Photoimmunology & Photomedicine. 25(3). 146–152. 7 indexed citations

10.

Panelli, Monica C., Mitchell E. Stashower, Herbert B. Slade, et al.. (2007). Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection. Genome biology. 8(1). R8–R8. 79 indexed citations

11.

Panelli, Monica C., Mitchell E. Stashower, Ping Jin, et al.. (2007). Gene expression profiling of cutaneous wound healing. Journal of Translational Medicine. 5(1). 11–11. 165 indexed citations

12.

Torres, Abel, et al.. (2007). Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream. Journal of Translational Medicine. 5(1). 7–7. 44 indexed citations

13.

Schön, Michael P., Claudia Drewniok, Joachim Herz, et al.. (2003). Tumor-Selective Induction of Apoptosis and the Small-Molecule Immune Response Modifier Imiquimod. JNCI Journal of the National Cancer Institute. 95(15). 1138–1149. 205 indexed citations

14.

Miller, Richard L., John F. Gerster, Mary Owens, Herbert B. Slade, & Mark A. Tomai. (1999). Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug. International Journal of Immunopharmacology. 21(1). 1–14. 333 indexed citations

15.

Arany, István, Stephen K. Tyring, Margaret Stanley, et al.. (1999). Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. Antiviral Research. 43(1). 55–63. 100 indexed citations

16.

Tyring, Stephen K., István Arany, Margaret Stanley, et al.. (1998). A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod. The Journal of Infectious Diseases. 178(2). 551–555. 199 indexed citations

17.

Bleecker, Eugene R., David G. Tinkelman, Joe Ramsdell, et al.. (1998). Proventil HFA and Ventolin Have Similar Safety Profiles During Regular Use. CHEST Journal. 113(2). 290–296. 31 indexed citations

18.

Dube, Syamalima, et al.. (1997). HIV Type 1 Isolate Z321, the Strain Used to Make a Therapeutic HIV Type 1 Immunogen, Is Intersubtype Recombinant. AIDS Research and Human Retroviruses. 13(4). 357–361. 50 indexed citations

19.

Slade, Herbert B., John G. Turner, Cameron F. Abrams, Dennis J. Carlo, & Jonas Salk. (1992). Immunotherapy of HIV-Seropositive Patients: Preliminary Report on a Dose-Ranging Study. AIDS Research and Human Retroviruses. 8(8). 1329–1331. 2 indexed citations

20.

Slade, Herbert B. & Stanley A. Schwartz. (1989). Antigen-Driven Immunoglobulin Production by Human Colostral Lymphocytes. Pediatric Research. 25(3). 295–299. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact